Here are four essential things to know and talk about when it comes to prostate cancer: ...

In a striking and unfiltered interview, Hunter Biden has broken his silence over what many have called one of the most ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

Icotrokinra is currently being developed through a licensing and collaboration agreement between Protagonist and J&J.

When standard cancer treatments begin to fail, especially in aggressive or advanced stages, oncologists are increasingly ...

European Union approves Bayer’s Nubeq for patients with advanced prostate cancer: Berlin Tuesday, July 22, 2025, 11:00 Hrs [IST] The European Commission has granted marketing au ...

Berlin: Bayer has received marketing authorization from the European Commission in the European Union (EU) for Nubeqa ...

In patients with biochemical recurrence after prostate cancer surgery, the optimal duration of hormone therapy after salvage radiation therapy has been debated.

Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.

The European Commission has granted marketing authorization in the European Union (EU) for German pharma major Bayer’s Nubeqa ...

Testosterone propionate was once a common treatment for men with low testosterone. It’s a synthetic version of the naturally ...